Position in JNJ
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$830,735
+$62,461 QoQ
Shares Held
3,271
+4.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#3,199
of 4,676 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Millennium Capital Advisors, LLC holds $10,220,889 across 6 Drug Manufacturers - General names. JNJ ranks #4 (8.1% of the industry book) .
All Filings in JNJ
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $830,735 | 3,271 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $768,274 | 3,143 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $650,236 | 3,142 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $578,510 | 3,120 | Shares | Sole | 2026-02-18 | |
| 2025-06-30 | $582,283 | 3,812 | Shares | Sole | 2026-02-18 | |
| 2025-03-31 | $670,325 | 4,042 | Shares | Sole | 2026-02-18 | |
| 2024-12-31 | $619,985 | 4,287 | Shares | Sole | 2026-02-18 | |
| 2024-09-30 | $779,022 | 4,807 | Shares | Sole | 2026-02-18 | |
| 2024-06-30 | $699,667 | 4,787 | Shares | Sole | 2026-02-18 | |
| 2024-03-31 | $796,803 | 5,037 | Shares | Sole | 2026-02-18 | |
| 2023-12-31 | $789,499 | 5,037 | Shares | Sole | 2026-02-18 | |
| 2023-09-30 | $791,677 | 5,083 | Shares | Sole | 2026-02-18 | |
| 2023-06-30 | $876,759 | 5,297 | Shares | Sole | 2026-02-18 | |
| 2023-03-31 | $808,945 | 5,219 | Shares | Sole | 2026-02-18 | |
| 2022-12-31 | $948,433 | 5,369 | Shares | Sole | 2026-02-18 | |
| 2022-09-30 | $874,466 | 5,353 | Shares | Sole | 2026-02-18 | |
| 2022-06-30 | $954,826 | 5,379 | Shares | Sole | 2026-02-18 | |
| 2022-03-31 | $983,272 | 5,548 | Shares | Sole | 2026-02-18 | |
| 2021-12-31 | $946,872 | 5,535 | Shares | Sole | 2026-02-18 | |
| No filing history on record for this holder in this stock. | ||||||